Company Number: 13143352

Analysis Date: 2025-07-29 14:03 UTC

Financial Health Assessment: CRUNCHNETIC LTD (As at 31 December 2023)

---

1. Financial Health Score: D

Explanation: The company exhibits serious financial distress symptoms with significant net liabilities, negative working capital, and erosion of shareholder funds. While still active and compliant with filing deadlines, the financial "vital signs" suggest an unhealthy state requiring urgent attention.

---

2. Key Vital Signs

Metric	2023 Value (£)	Interpretation
Fixed Assets	1,008	Minimal long-term assets, indicating limited investment in infrastructure or capital resources.
Current Assets	26,624	Low short-term liquidity; insufficient to cover current liabilities.
Current Liabilities	124,385	High short-term obligations; major pressure on liquidity.
Net Current Assets	-96,832	Negative working capital — a symptom of liquidity crisis.
Total Assets Less Current Liabilities	-95,824	Company owes more than it owns, indicating insolvency risks.
Net Assets / Shareholders' Funds	-97,857	Negative equity, showing accumulated losses exceed invested capital.

Trend Analysis:
Compared to 2022, there has been a slight improvement in net liabilities (from -£137,537 to -£97,857), but the company remains deeply insolvent by balance sheet standards. Current liabilities remain high relative to current assets, showing ongoing liquidity stress.

---

3. Diagnosis

CRUNCHNETIC LTD is exhibiting classic symptoms of financial distress akin to a patient suffering from chronic malnutrition—its balance sheet shows prolonged "deficit" and inability to maintain healthy reserves. The negative net current assets indicate the company cannot cover its short-term debts with available liquid resources, a vital sign of poor financial health.

Despite the company being active and compliant with statutory filings, the substantial negative equity (net assets) suggests accumulated losses or undercapitalization. The absence of employees and very low fixed assets indicate minimal operational scale or investment, possibly reflecting a startup or a company in early-stage development but struggling to generate positive cash flow.

The change in director and the 75-100% shareholding concentration in one individual (Mr Simon Neil Weston) may indicate recent attempts at restructuring or recapitalization, though no direct evidence of capital infusion is visible in the accounts (share capital remains nominal at £100).

---

4. Recommendations

Short-term (Stabilization):

• Improve Liquidity: Seek to negotiate extended payment terms with creditors or arrange short-term financing to cover immediate liabilities. Healthy cash flow is critical to avoid insolvency.
• Cost Control: Minimise operating expenses and avoid further debt accumulation to prevent worsening the working capital deficit.
• Capital Injection: The principal shareholder should consider injecting fresh equity or convertible debt to shore up the balance sheet and improve solvency.

Medium-term (Recovery and Growth):

• Business Model Review: Conduct a strategic review to identify revenue generation opportunities or cost efficiencies; the advertising agency sector (SIC 73110) is competitive and requires investment in client acquisition and service delivery.
• Financial Monitoring: Implement robust cash flow forecasting and management processes to detect and address "symptoms" of distress early.
• Professional Advice: Engage turnaround specialists or financial advisors experienced in micro-entity recovery to develop a restructuring plan and explore potential refinancing or partnerships.

---

Medical Analogy Summary:

CRUNCHNETIC LTD’s financial health resembles a patient with severe nutrient deficiency and compromised immune function—its resources (assets) are insufficient to meet obligations (liabilities), placing it at high risk of "organ failure" (insolvency). Immediate intervention is essential to restore liquidity and rebuild capital, or the company may face a terminal financial condition.

---